Cognitive Behavioral Therapy for Alcohol Use Disorder in HIV
(TALC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of combining brief intervention with cognitive-behavioral therapy (CBT) in reducing unhealthy alcohol use among people living with HIV. The study compares two groups: one receiving only a brief intervention and the other receiving both the brief intervention and CBT through telemedicine, known as the Common Elements Treatment Approach (CETA). It targets individuals with HIV who are already receiving care in Alabama, have a history of unhealthy alcohol use, and can use a mobile phone. As an unphased trial, this study allows participants to contribute to innovative research that could enhance treatment strategies for others facing similar health challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Common Elements Treatment Approach (CETA) through Telemedicine is generally safe. Studies have found that CETA effectively reduces unhealthy alcohol use and improves mental health. In one study, participants who received both a brief intervention and CETA showed better results than those who only received the brief intervention. No major safety concerns have been reported with CETA.
CETA involves discussing problems and finding better coping strategies, which most people find manageable. Since this study does not involve medication or physical treatments, the risk of side effects is lower. Overall, CETA appears to be a safe option for addressing alcohol use and mental health issues in people living with HIV.12345Why are researchers excited about this trial?
Researchers are excited about the Common Elements Treatment Approach (CETA) via telemedicine for alcohol use disorder in individuals with HIV because it offers flexibility and accessibility that traditional in-person therapies like cognitive behavioral therapy (CBT) or motivational interviewing may lack. CETA is delivered over the phone, making it easier for participants to receive consistent support without the need for travel, which is particularly beneficial for those with mobility challenges or living in remote areas. Additionally, CETA incorporates multiple therapeutic elements tailored to address both alcohol use and the unique mental health challenges faced by individuals with HIV, providing a more holistic approach to treatment.
What evidence suggests that this trial's treatments could be effective for alcohol use disorder in HIV?
This trial will compare the effectiveness of two treatments for alcohol use disorder in individuals with HIV. Participants in one arm will receive the Common Elements Treatment Approach (CETA) via telemedicine, which has shown promise in reducing unhealthy alcohol use and mental health symptoms. Research indicates that CETA can significantly reduce alcohol use and depression, particularly compared to other interventions. Participants in the other arm will receive an Alcohol Brief Intervention (BI) as an active comparator. Previous studies have demonstrated that CETA might also improve HIV treatment outcomes by addressing mental health issues that can act as barriers. Overall, CETA appears promising in helping people with HIV manage alcohol use and improve their health.12346
Who Is on the Research Team?
Karen Cropsey, Psy.D.
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults over 18 living with HIV in Alabama who drink alcohol at levels considered unhealthy. They must be getting care at certain clinics and able to use a mobile phone. People with active suicidal thoughts, psychosis, risk of severe alcohol withdrawal, or those who can't speak English well enough for therapy are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 1 phone session of Alcohol Brief Intervention (BI) or 6 to 12 weekly phone sessions of BI + Common Elements Treatment Approach (T-CETA) via telephone
Follow-up
Participants are monitored for safety and effectiveness after treatment, with follow-ups at 6 and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Alcohol Brief Intervention (BI)
- Common Elements Treatment Approach (CETA) via Telemedicine
Trial Overview
The study tests if adding cognitive-behavioral therapy (CETA) via telemedicine to a brief intervention helps reduce unhealthy alcohol use and improve mental health and HIV outcomes better than the brief intervention alone.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be provided with 6 to 12 weekly CETA sessions via telephone.
At the time of trial enrollment, participants will receive a session of alcohol brief intervention (BI) via telephone.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Published Research Related to This Trial
Citations
Efficacy of the Common Elements Treatment Approach ...
In summary, BI plus referral to CETA led to a clinically and statistically significantly greater reduction in unhealthy alcohol use, depression ...
Common Elements Treatment Approach HIV Alcohol ...
In pilot study, the BI plus CETA reduced alcohol use and mental health symptoms more at 6 months than the BI alone. Whether the BI is superior to standard of ...
Integration of Common Elements Treatment Approach ...
In a randomized controlled trial (RCT), we previously reported that CETA was clinically effective in reducing UAU and mental health comorbidities among PWH in ...
Effectiveness of the Common Elements Treatment ...
CETA has the potential to improve HIV treatment outcomes by addressing underlying barriers to retention and adherence (e.g., IPV and other co- ...
Study protocol of the ZCAP randomized controlled trial
The trial is a first step in establishing the effectiveness of CETA at reducing unhealthy alcohol use and comorbidities among PLWH in SSA.
A randomized controlled trial | PLOS Medicine
Results showed that CETA was more effective than TAU-Plus in reducing IPV and hazardous alcohol use among high-risk couples in Zambia.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.